Physician profile
Dane Johnson
NPI 1730479932
$3,191.71
in general payments reported to CMS, 2019-2025
19 companies · $620 in 2025
The $620 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $40.13 · 2021: $174 · 2022: $899 · 2023: $861 · 2024: $348 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,719 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,719.09 |
| Education | $111.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,453.20 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Lithovue |
| Endo Pharmaceuticals INC. | $603.02 | 2019-2024 | Xiaflex, Aveed |
| Calyxo, INC. | $190.13 | 2024-2025 | Cvac Aspiration System |
| Endo USA, INC. | $153.83 | 2024-2025 | Xiaflex |
| Coloplast Corp | $142.39 | 2019 | |
| Cook Medical LLC | $131.96 | 2022 | |
| Janssen Biotech, INC. | $94.09 | 2023-2025 | Tremfya, Stelara |
| Merck Sharp & Dohme LLC | $87.10 | 2021 | |
| Uroviu Corporation | $61.11 | 2022 | |
| Photocure INC | $44.39 | 2021 | |
| Tolmar, INC. | $43.99 | 2023 | |
| Myriad Genetic Laboratories, INC. | $39.73 | 2023-2024 | Prolaris |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Urogen Pharma, INC. | $24.65 | 2025 | |
| Novo Nordisk INC | $23.05 | 2025 | Wegovy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $20.05 | 2025 | |
| 180 Medical, INC. | $18.68 | 2022 | |
| Acerus Pharmaceuticals Corporation | $14.29 | 2022 | |
| Metuchen Pharmaceuticals | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.